Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats-Reference-Cited by-同舟云学术

Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats

Published:1988-01 Issue:1 Volume:29 Page:89-92
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Asin K.E.,Montana W.E.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference25 articles.

1. Turning behavior following nigral injections of dopamine agonists and glycine;Andrews;Eur J Pharmacol,1982

2. Behavioral stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats;Arnt;Eur J Pharmacol,1985

3. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behavior induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions;Arnt;Fed J Pharmacol,1984

4. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain;Boyson;J Neurosci,1986

5. Dendritic release of dopamine in the substantia nigra;Cheramy;Nature,1981

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coexistence of D3R typical and atypical signaling in striatonigral neurons during dopaminergic denervation. Correlation with D3nf expression changes;Synapse;2020-03-06

2. Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction Among Glutamate, Dopamine, and GABA;Biomolecules;2019-09-20

3. Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification;Experimental Neurology;2017-12

4. Extrastriatal dopaminergic circuits of the basal ganglia;Frontiers in Neuroanatomy;2010

5. S33138 [N-[4-[2-[(3aS,9bR)-8-Cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent. II. A Neurochemical, Electrophysiological and Behavioral Characterization in Vivo;Journal of Pharmacology and Experimental Therapeutics;2007-11-16